Literature DB >> 2690187

Copper complexes offer a physiological approach to treatment of chronic diseases.

J R Sorenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690187     DOI: 10.1016/s0079-6468(08)70246-7

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  28 in total

1.  Physiological studies on the effect of copper nicotinate (Cu-N complex) on the fish, Clarias gariepinus, exposed to mercuric chloride.

Authors:  M Bassam Al-Salahy
Journal:  Fish Physiol Biochem       Date:  2010-10-07       Impact factor: 2.794

2.  Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.

Authors:  Sreeja Chakraborty; Esha Sehanobish; Munna Sarkar
Journal:  J Biol Inorg Chem       Date:  2012-01-20       Impact factor: 3.358

3.  Coordination of copper with aspirin enhances its anti-platelet aggregation activity.

Authors:  L Weiping; Y K Yang; H Z Xiong; X Z Cheng; Z H Chen; Z Q Shen; L Li
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

4.  Hypoglycemic effect of copper(II) acetate imidazole complexes.

Authors:  A S Abdul-Ghani; A L Abu-Hijleh; N Nahas; R Amin
Journal:  Biol Trace Elem Res       Date:  1996-08       Impact factor: 3.738

5.  Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta.

Authors:  A M Emsley; J Y Jeremy; G N Gomes; G D Angelini; F Plane
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism.

Authors:  M Roch-Arveiller; V Revelant; D Pham Huy; L Maman; J Fontagne; J R Sorenson; J P Giroud
Journal:  Agents Actions       Date:  1990-08

Review 7.  Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation.

Authors:  G Berthon
Journal:  Agents Actions       Date:  1993-07

Review 8.  Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Authors:  R Milanino; M Marrella; R Gasperini; M Pasqualicchio; G Velo
Journal:  Agents Actions       Date:  1993-07

9.  Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis.

Authors:  A Keshavarzian; J Haydek; R Zabihi; M Doria; M D'Astice; J R Sorenson
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.

Authors:  Myrna Hurtado; Umesh T Sankpal; Jaya Chhabra; Deondra T Brown; Rajasekhar Maram; Rafid Patel; Raj K Gurung; Jerry Simecka; Alvin A Holder; Riyaz Basha
Journal:  Invest New Drugs       Date:  2018-05-15       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.